The Gloucester Comfort Scale (GCS) is a clinician-assessed scoring system used to evaluate patient comfort during procedures such as colonoscopy. It is a 1–5 scale, with higher scores indicating greater discomfort or pain experienced by the patient.
The Gloucester Comfort Scale (GCS) is a clinician-assessed scoring system used to evaluate patient comfort during procedures such as colonoscopy. It is a 1–5 scale, with higher scores indicating greater discomfort or pain experienced by the patient. The GCS is widely used by clinicians to rate patient comfort based on their observations during the procedure. However, the study you referenced highlights significant limitations in the accuracy of GCS scores when compared to patient-reported experiences.
Key findings regarding GCS scores from the study:
1. **Discrepancies Between Clinician and Patient Scores**: Clinicians often underestimated or overestimated patient discomfort and pain levels when using the GCS. Specifically:
2. **Underestimation in Moderate-to-Severe Cases**: The mismatch was particularly pronounced in patients with moderate-to-severe symptoms (scores ≥3). Among these patients:
3. **Low Agreement Between Clinician and Patient Scores**: Statistical analysis showed weak alignment between clinician-reported GCS scores and patient-reported measures:
4. **Recommendation for Improvement**: The study suggests that the GCS alone may not accurately reflect patients' true experiences of discomfort and pain during colonoscopy. To improve patient-centered care, it recommends incorporating patient-reported experience measures (PREMs), such as the Newcastle ENDOPREM, which directly capture patients' perceptions on a similar 1–5 scale.
In summary, while the Gloucester Comfort Scale is a commonly used tool, its reliability is limited when it comes to accurately assessing discomfort and pain from the patient's perspective. Integrating patient-reported measures alongside clinician assessments is strongly advised to ensure a more accurate and holistic evaluation of patient comfort during medical procedures.
Introduction: Endoscopic metabolic therapies have emerged as less invasive alternatives to bariatric surgery for patients with obesity and poorly controlled type 2 diabetes mellitus (T2DM). The EndoBarrier duodenal-jejunal bypass liner (DJBL) is an endoscopically placed...
Introduction: Endoscopic ultrasound (EUS)-guided transmural drainage is the standard minimally invasive treatment for symptomatic necrotizing pancreatitis. However, the optimal timing of direct endoscopic necrosectomy (DEN) following drainage remains uncertain. While the conventional step-up approach reserves...
Introduction: Bevacizumab is widely used in metastatic colorectal cancer (mCRC) because of its survival benefits but is associated with impaired wound healing, gastrointestinal perforation, and bleeding. These concerns often lead clinicians to delay endoscopic procedures...
Introduction: Endoscopic submucosal dissection (ESD) enables en bloc resection of large colorectal neoplasms with excellent oncological outcomes. However, concerns about perforation have limited its widespread adoption. This large prospective multicenter study evaluated the incidence, risk...
Introduction: Obesity has become one of the greatest global health challenges. New incretin-based therapies—including semaglutide, tirzepatide, resmetirom, and SGLT2 inhibitors such as empagliflozin—have transformed the treatment of obesity, diabetes, and MASLD. However, many patients discontinue...
Introduction: Endoscopic ultrasound-guided fine-needle biopsy (EUS-FNB) is the standard technique for diagnosing solid pancreatic lesions. Traditionally, biopsy specimens are processed for cytology, often requiring on-site cytopathology support. This multicenter prospective study evaluated whether directly placing...
We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.